ANI Pharmaceuticals Reports Third-Quarter Revenue of $290.8 Million
Story updates
11:52:39 AM UTC
SquawkNews
*-- Earnings Flash (ANIP) ANI Pharmaceuticals, Inc. Reports Q3 Revenue $290.8M, vs.
11:58:00 AM UTC
SquawkNews
ANI Pharmaceuticals reported Q3 2026 revenue of $290.8M, up 27.6% year over year, and diluted GAAP EPS of $1.51 versus $1.13. The company also announced a recommended offer for Egetis Therapeutics, subject to closing conditions.Material DetailsContext by AI AnalystThis earnings report adds quarterl…